New ceilings for pharmaceuticals and doubling of the discount for pharmacists and businesses. Intramoenia and medical liability insurance. Fines for those who sell tobacco to minors. These are Balduzzi's proposals. But the CDM could ask for more incisive interventions and cuts.
26 JUN – In less than a week the cards will be revealed, but for the moment a lot of mystery and also a lot of uncertainty reigns over the "Balduzzi Decree" which should intervene at 360° on health care. No drafts are circulating and the rumors that run after each other speak of a slowdown, yesterday, by the pre-council of ministers, on the provision that the Minister of Health would have presented in preview. Text to be reviewed, therefore. Perhaps also with the aim of producing some more savings than those envisaged by Minister Balduzzi and which, according to what he writes today the sun 24 hours, should amount to 8 billion euros distributed over the next 3 years (to be exact, 1.085 billion in 2012, then 3.46 billion in 2013 and the remaining 3.57 billion in 2014).
Balduzzi would like to achieve this goal by intervening across the board on healthcare: from pharmaceutical spending to specialist spending, from goods and services to accredited nursing homes, from intramoenia to medical liability, from the abolition of some institutions to tobacco fines, up to the Red Cross and the relaunch of the electronic health record.
According to rumors of Only 24 Hours, in particular, the Balduzzi decree would propose a lowering of the ceiling for territorial pharmaceutical expenditure from 13.3% to 11.3% (net of the reimbursement price paid by citizens), shifting resources to hospital pharmaceutical expenditure, the ceiling of which would rise from the current 2.4% to 3.2%. In any case, it would be confirmed that in the event of this expenditure item being exceeded, the companies will be called upon to settle the 35% (today the hospital expenditure shelf is borne entirely by the Regions) as envisaged by the maneuver last July.
News also for pharmacies for which - but only for the current year - a doubling of the discount to the NHS at their expense would be envisaged. The same fate for companies, to which, however, Balduzzi would like to give more certainty on the marketing of innovative drugs in the Regions. To optimize the use of medicines, the Minister of Health would also like to experiment with new packaging systems, even personalized ones, and for the distribution of medicines used in hospitals.
For doctors, the reform of the intramoenia is proposed, which will in any case provide for a pror
